Industrial &

Agricultural Biotech

Food security and sustainability of resources are concerns that are rarely far from the headlines. While solutions to these challenges must be multi-disciplinary, industrial and agricultural biotechnology has already been used to transform efficiency across a wide variety of industrial process and offers huge potential to do more.

Industrial enzymes are used in myriad industrial processes, with novel enzymes and novel applications continuing to be found. Our IP experts have a long history of involvement in protein engineering and industrial enzyme technology, including extensive offensive and defensive opposition work at the European Patent Office. The team also has particular experience in industrial microbiology, biofuel production and biosourced polymers, working alongside our chemists.

Gene editing technologies such as CRISPR are beginning to radically alter the field of functional genomics and the engineering of industrial microbes and crops.  We are proud to have been at the forefront of developments in this area, having worked with innovators of the CRISP-Cas9 technology, as well as those using it to develop new commercial products.

In the area of plant bioscience, the political interest in food production has introduced regulatory and legal complexities. Our specialised and expert plant bioscience team understand the toolkit of approaches which can be used to protect innovation in this area and the need for a flexible approach which can adapt to the shifting landscape. As well as patents and trade marks, we can offer advice and assistance in obtaining Plant Variety Rights (PVRs) and National Listings in both the UK and Europe.

Read more about protecting your innovations

Pink-Pentagons-HQ

Enzyme engineering & industrial fermentation

Pink-Pentagons-HQ

Future & functional foods

Pink-Pentagons-HQ

Microbiome

opps-report-1-1-resized

Special Report

Opposition Trends in the Life Sciences Sector

We published this report to help tackle the key questions our clients ask regularly. In spring 2019, we undertook 350 hours of research, analysing more than 5,000 opposition cases filed at the European Patent Office over the last ten years, studying the timelines for hundreds of oppositions both before and after the EPO’s opposition streamlining initiative.

View the 2020 addendum for this report, based on information as it appeared on the EPO Register on 10 January 2021 and from bulk data sets extracted on this date.

Read our latest blogs

Most opposed companies at the EPO in 2024

Most opposed companies at the EPO in 2024

by Katherine Green

Opposition activity at the European Patent Office is often a strong indicator of a technology’s commercial relevance. We analysed the companies holding the highest numbers of European patents that ...

Mewburn Ellis is proud to have worked on 24 of the 100 top-selling pharmaceuticals of 2024

Mewburn Ellis is proud to have worked on 24 of the 100 top-selling pharmaceuticals of 2024

by Adam Gregory

Mewburn Ellis works with some of the world’s most important pharmaceuticals and biologics across a broad range of therapeutic areas.

Optimising Training for the Menstrual Cycle

Optimising Training for the Menstrual Cycle

by Sarah Harvey

In recent years, there's been a noticeable shift in how we approach female athletic performance, with increasing attention paid to the menstrual cycle and its impact on training outcomes. No longer a ...

We work at every stage of the IP lifecycle

Protect

Drafting, Filing & Prosecution
Portfolio Management
Searching & Watching
Renewals & EP Validations

Defend

Pre-action Advice
Oppositions & Appeals
Litigation
Alternative Dispute Resolution

Exploit

Strategic Advice
Commercial Issues
Transactions
Corporate Support

Forward Magazines Overlapping 8

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.